Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration techniques like follicular unit transplant surgery and follicular unit extraction are effective, with ideal graft placement density between 20-30 units per cm². Medications like Minoxidil and Finasteride can help maintain and regrow hair.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Many men with androgenic alopecia also have dyslipidemia.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

There is no significant link between male pattern baldness and insulin resistance.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

There's no significant link between blood fat levels and male pattern baldness.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

PCOS increases the risk of heart disease and type 2 diabetes in women.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

The hCG diet and testosterone therapy can cause hair loss in some people.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.